Literature DB >> 16406574

Caring for survivors of childhood cancers: the size of the problem.

H L Curry1, S E Parkes, J E Powell, J R Mann.   

Abstract

Many survivors of childhood cancer have significant health problems due to their illness or treatment. This population-based study examines the number of long-term survivors, their disabilities and consequent long-term care needs. Survival rates for children diagnosed with cancer between 1960 and 1999 in the West Midlands, United Kingdom (UK), were used to estimate future long-term survivor numbers. Treatment and late effects data on a cohort of patients surviving for more than 5 years were used to consider continuing care needs. Between the 1960s and 1990s, 5-year survival increased from 23% to 70%. There were 98 5-year survivors in 1970, and numbers may exceed 2,100 by the end of 2005. Most (at least 61%) survivors in the West Midlands Region have one or more chronic medical problems and may require multidisciplinary care. We conclude that, in order to determine how to provide cost-effective care for this increasing population, protocol delivered management with audit is needed.

Entities:  

Mesh:

Year:  2006        PMID: 16406574     DOI: 10.1016/j.ejca.2005.11.003

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  31 in total

1.  Retrospective estimation of heart and lung doses in pediatric patients treated with spinal irradiation.

Authors:  Daniel Gasic; Per Munck Af Rosenschöld; Ivan R Vogelius; Maja V Maraldo; Marianne C Aznar; Karsten Nysom; Thomas Björk-Eriksson; Søren M Bentzen; Nils Patrik Brodin
Journal:  Radiother Oncol       Date:  2018-05-30       Impact factor: 6.280

2.  The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability.

Authors:  E Sieswerda; R L Mulder; I W E M van Dijk; E C van Dalen; S L Knijnenburg; H J H van der Pal; M S Mud; R C Heinen; H N Caron; L C M Kremer
Journal:  J Cancer Surviv       Date:  2013-04-30       Impact factor: 4.442

3.  Marriage and parenthood among childhood cancer survivors: a report from the Italian AIEOP Off-Therapy Registry.

Authors:  Emanuele Pivetta; Milena M Maule; Paola Pisani; Daniela Zugna; Riccardo Haupt; Momcilo Jankovic; Maurizio Aricò; Fiorina Casale; Anna Clerico; Luca Cordero di Montezemolo; Valentina Kiren; Franco Locatelli; Giovanna Palumbo; Andrea Pession; Marta Pillon; Nicola Santoro; Monica Terenziani; Maria Grazia Valsecchi; Elisa Dama; Corrado Magnani; Franco Merletti; Guido Pastore
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

4.  Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity.

Authors:  Maria A Mitry; Dimitri Laurent; Britny L Keith; Elizabeth Sira; Carol A Eisenberg; Leonard M Eisenberg; Sachindra Joshi; Sachin Gupte; John G Edwards
Journal:  Am J Physiol Cell Physiol       Date:  2020-01-08       Impact factor: 4.249

Review 5.  Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium.

Authors:  Wendy van Dorp; Renée L Mulder; Leontien C M Kremer; Melissa M Hudson; Marry M van den Heuvel-Eibrink; Marleen H van den Berg; Jennifer M Levine; Eline van Dulmen-den Broeder; Natascia di Iorgi; Assunta Albanese; Saro H Armenian; Smita Bhatia; Louis S Constine; Andreas Corrias; Rebecca Deans; Uta Dirksen; Clarisa R Gracia; Lars Hjorth; Leah Kroon; Cornelis B Lambalk; Wendy Landier; Gill Levitt; Alison Leiper; Lillian Meacham; Alesandro Mussa; Sebastian J Neggers; Kevin C Oeffinger; Alberto Revelli; Hanneke M van Santen; Roderick Skinner; Andrew Toogood; William H Wallace; Riccardo Haupt
Journal:  J Clin Oncol       Date:  2016-07-25       Impact factor: 44.544

6.  A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Leontien C M Kremer; Renée L Mulder; Kevin C Oeffinger; Smita Bhatia; Wendy Landier; Gill Levitt; Louis S Constine; W Hamish Wallace; Huib N Caron; Saro H Armenian; Roderick Skinner; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2012-12-31       Impact factor: 3.167

Review 7.  Wilms tumour: prognostic factors, staging, therapy and late effects.

Authors:  Sue C Kaste; Jeffrey S Dome; Paul S Babyn; Norbert M Graf; Paul Grundy; Jan Godzinski; Gill A Levitt; Helen Jenkinson
Journal:  Pediatr Radiol       Date:  2007-11-17

Review 8.  Late effects of treatment for wilms tumor.

Authors:  Karen D Wright; Daniel M Green; Najat C Daw
Journal:  Pediatr Hematol Oncol       Date:  2009-09       Impact factor: 1.969

Review 9.  Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example.

Authors:  Rachel Shukrun; Naomi Pode Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2013-06-13       Impact factor: 3.714

10.  Amifostine reduces the seminiferous epithelium damage in doxorubicin-treated prepubertal rats without improving the fertility status.

Authors:  Vanessa Vendramini; Estela Sasso-Cerri; Sandra M Miraglia
Journal:  Reprod Biol Endocrinol       Date:  2010-01-10       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.